focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQinetiq Regulatory News (QQ.)

Share Price Information for Qinetiq (QQ.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 373.60
Bid: 372.60
Ask: 373.40
Change: 5.00 (1.36%)
Spread: 0.80 (0.215%)
Open: 367.00
High: 373.60
Low: 367.00
Prev. Close: 368.60
QQ. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

21 Mar 2019 07:00

RNS Number : 5031T
QinetiQ Group plc
21 March 2019
 

QinetiQ Group plc Directorate Change. Non-executive Director Appointment.

Mark Elliott to retire as Chairman in July 2019

Neil Johnson appointed to succeed him

21 March 2019 - QinetiQ Group plc today announced the appointment of Neil Johnson as an independent Non-executive Director to the QinetiQ Board with effect from 2 April 2019. Neil will assume the role of Chairman when Mark Elliott retires from the QinetiQ Board at the conclusion of the Annual General Meeting on 24 July 2019. On appointment, Neil will become a member of the Audit, Remuneration, Nominations, Risk & CSR, and Security Committees.

Neil Johnson has extensive Board experience and is currently Chairman of the FTSE250 global polymers and specialist chemicals company Synthomer. Until March 2017 he also chaired defence technology company e2v technologies.

After Sandhurst and the Army, Neil spent much of his early career in the automotive and engineering industries. He was worldwide Sales and Marketing Director at Jaguar before being seconded to the UK Ministry of Defence to command 4th Battalion The Royal Green Jackets with an operational role in Germany. After the three-year secondment, he returned to industry with British Aerospace, initially running Land Rover and then all of its European automotive operations. Neil was later CEO of the RAC where he managed the demutualisation and sale process.

For the past seven years, Neil has been Senior Independent Director of the Business Growth Fund. He is also a former Director General of the Engineering Employers Federation and was a Home Office appointed Independent Member of the Metropolitan Police Authority in the years running up to the London Olympics in 2012.

Michael Harper, Senior Independent Director, who led the process to appoint a successor to Mark said:

"We undertook a rigorous, independent search for candidates who could enhance the delivery of our vision for QinetiQ, and provide the right support and constructive challenge to our executive team. We are delighted that Neil Johnson will be joining us. He is a former CEO and seasoned plc Chairman, and has experience in defence, with both Army service and later as an advisor to the UK Ministry of Defence.

"On behalf of the Board I would like to thank Mark for the significant contribution he has made to QinetiQ over the past ten years during which time he has overseen the rebuilding of our balance sheet and implementation of a strategy to deliver long-term and sustainable growth."

Mark Elliott said:

"It has been a great privilege to chair QinetiQ during a period of considerable change. The Company has a renewed strategic focus and a strong executive team. With his extensive and varied boardroom experience, Neil Johnson is a tremendous choice to be my successor. I look forward to welcoming him to the Board when he joins in April."

Neil Johnson said:

"I am delighted to be joining the Board of QinetiQ and to be succeeding Mark in due course. During his successful tenure, sound foundations have been laid for the future development of the business. I will be joining a Company whose performance is gathering momentum thanks to a clear strategy, strong leadership and a robust balance sheet. The future is exciting for QinetiQ and I am looking forward to working with the Board of Directors and the executive team."

Neil Johnson other appointments

Neil Johnson retires from his role as Chairman of Motability Operations Group plc at the end of March 2019, having served nine years on the Board.

It has also been announced that Neil will step down as Chairman of Centaur plc prior to becoming QinetiQ Chairman in July 2019.

Since May 2016, Neil has been Chairman of Electra plc, the former private equity firm which has returned more than £2bn to its shareholders during this period. As agreed by shareholders, Electra is now running off its final few investments and reducing overheads prior to closing the fund once that process has been successfully concluded.

He remains Chairman of Synthomer plc, the global polymers and specialist chemicals business, and is Senior Independent Director at the Business Growth Fund.

9.6.11R and 9.6.13R of the Listing Rules of the UK Listing Authority

This notice is given in fulfilment of the obligation under paragraph 9.6.11R of the Listing Rules. There are no further details that are required to be disclosed in respect of Neil Johnson's appointment under paragraph 9.6.13 of the Listing Rules.

S430(2B) Companies Act 2006

Mark Elliott has not and will not receive any loss of office payments, nor will he be paid any further remuneration for his service as a Director of QinetiQ Group plc, other than fees due for his services up to the date he leaves.

Fees

Neil Johnson's fees will be £49,000 per annum payable from 2 April 2019. Upon his appointment as Chairman his fees will be £250,000 per annum.

About QinetiQ:

QinetiQ (QQ.L) is a leading science and engineering company operating primarily in the defence, security and critical infrastructure markets. We work in partnership with our customers to solve real world problems through innovative solutions delivering operational and competitive advantage. Visit our website www.QinetiQ.com. Follow us on LinkedIn and Twitter @QinetiQ. Visit our blog www.QinetiQ-blogs.com.

For further information please contact:

David Bishop, Group Director Investor Relations and Communications:

+44 (0) 7920 108675

Ian Brown, Group Head of Investor Relations:

+44 (0) 7908 251123

Jon Hay-Campbell, Group Head of Communications

+44 (0) 7500 856953

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOADBLFLKXFLBBB
Date   Source Headline
5th Mar 20247:00 amRNSTransaction in Own Shares
4th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 20247:00 amRNSTransaction in Own Shares
29th Feb 20244:00 pmRNSTotal Voting Rights
29th Feb 20247:00 amRNSTransaction in Own Shares
28th Feb 20247:00 amRNSTransaction in Own Shares
27th Feb 20247:00 amRNSTransaction in Own Shares
26th Feb 20247:00 amRNSTransaction in Own Shares
23rd Feb 20247:00 amRNSTransaction in Own Shares
22nd Feb 20247:00 amRNSTransaction in Own Shares
21st Feb 20247:00 amRNSTransaction in Own Shares
20th Feb 20247:00 amRNSTransaction in Own Shares
19th Feb 20247:00 amRNSTransaction in Own Shares
16th Feb 20247:00 amRNSTransaction in Own Shares
15th Feb 20247:00 amRNSTransaction in Own Shares
14th Feb 20247:00 amRNSTransaction in Own Shares
13th Feb 20247:00 amRNSTransaction in Own Shares
9th Feb 20249:32 amRNSHolding(s) in Company
9th Feb 20247:00 amRNSTransaction in Own Shares
8th Feb 20247:00 amRNSTransaction in Own Shares
6th Feb 202411:55 amRNSResult of Meeting
5th Feb 20243:48 pmRNSDirector/PDMR Shareholding
19th Jan 20249:31 amRNSDirector/PDMR Shareholding
16th Jan 20247:00 amRNSQ3 Trading Update and Share Buyback Programme
10th Jan 20245:00 pmRNSDirector/PDMR Shareholding
12th Dec 20232:38 pmRNSDirector/PDMR Shareholding
12th Dec 20232:32 pmRNSDirector Declaration
22nd Nov 20238:29 amRNSHolding(s) in Company
20th Nov 20237:00 amRNS$170m US new business contract win
16th Nov 20237:00 amRNSInterim Results
13th Nov 20239:58 amRNSDirector/PDMR Shareholding
25th Oct 20237:23 amRNSInvestor Seminar
17th Oct 20238:00 amRNSDirector Declaration
11th Oct 20237:00 amRNSSecond Quarter Trading Update
10th Oct 20233:56 pmRNSDirector/PDMR Shareholding
4th Oct 20237:00 amRNS$127m contract win in the US (formerly Avantus)
3rd Oct 20237:00 amRNS$84m contract win in the US
28th Sep 20233:24 pmRNSDirector/PDMR Shareholding
12th Sep 20235:54 pmRNSDirector/PDMR Shareholding
31st Aug 20235:03 pmRNS$224m contract win in the US (formerly Avantus)
25th Aug 20232:23 pmRNSDirector/PDMR Shareholding
10th Aug 20234:31 pmRNSDirector/PDMR Shareholding
27th Jul 20234:45 pmRNSDirector/PDMR Shareholding
20th Jul 20232:00 pmRNSResult of AGM
20th Jul 20237:00 amRNSFirst Quarter Trading Update
11th Jul 20235:30 pmRNSDirector/PDMR Shareholding
21st Jun 202312:15 pmRNSDirector/PDMR Shareholding
14th Jun 202310:00 amRNSHolding(s) in Company
12th Jun 20234:00 pmRNSDirector/PDMR Shareholding
12th Jun 20232:00 pmRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.